Last deal

$72M

Amount

Series B

Stage

12.09.2023

Date

3

all rounds

$199M

Total amount

date founded

Financing round

General

About Company
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2020

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

ROME Therapeutics is using uncharted genetic material, known as the repeatome, to develop new therapies for cancer and autoimmune diseases. The company has identified several drug targets and has multiple discovery programs underway. They have a team of world-class leaders in oncology, immunology, virology, and machine learning to lead this exploration. ROME was launched in April 2020 and was incubated at GV, in collaboration with ARCH Venture Partners and Partners Innovation Fund. They are based in Cambridge, Mass and offer healthcare professionals new treatments for cancer and autoimmune diseases. For more information, please visit their website at www.rometx.com.
Contacts

Social url

Similar Companies
1000
Neon Therapeutics

Neon Therapeutics

Neon Therapeutics develops personalized vaccines and autologous T-cell therapies for cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

total rounds

3

total raised

$161M
Foghorn Therapeutics

Foghorn Therapeutics

Foghorn Therapeutics is developing therapies that change how genes turn "on" and "off".

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

total rounds

3

total raised

$221M
Harpoon Therapeutics

Harpoon Therapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company developing T cell engagers to treat cancer and other diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

South San Francisco, CA, USA

total rounds

5

total raised

$255M
Oniria Therapeutics

Oniria Therapeutics

Oniria Therapeutics develops precision oncology therapies to eliminate dormant tumor cells.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Barcelona, Spain

total rounds

1

total raised

$1.4M

Financials

Funding Rounds
3
3

Number of Funding Rounds

$199M

Money Raised

Their latest funding was raised on 12.09.2023. Their latest investor Partners Innovation Fund. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
12.09.2023
10
$72M
14.09.2021
8
$77M
27.04.2020
3
$50M
Section 32

Section 32

Section 32 is a venture capital firm that invests in technology, healthcare, and life sciences.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Health Care

Location

San Diego, CA, USA

count Of Investments

105

count Of Exists

4
GV

GV

GV is a venture capital firm that provides funding to innovative startups in various fields.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Mountain View, CA, USA

count Of Investments

820

count Of Exists

169
Co-Investors
Investors
18
2

Number of lead investors

18

Number of investors

Investor 
Lead 
Round 
Partners 
Partners Innovation Fund

Partners Innovation Fund

The Innovation Fund accelerates healthcare technology development and attracts external capital.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Boston, MA, USA

count Of Investments

33

count Of Exists

6
Bristol Myers Squibb

Bristol Myers Squibb

Bristol-Myers Squibb is a pharmaceuticals and nutritional products company.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Pharmaceuticals, Health Care, Manufacturing

Location

New York, NY, USA

total rounds

5

total raised

$23.58B

count Of Investments

77

count Of Exists

1
Johnson & Johnson Innovation – JJDC

Johnson & Johnson Innovation – JJDC

JJDC helps innovative healthcare ideas become real solutions for patients.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care

Location

Cambridge, MA, USA

count Of Investments

79

count Of Exists

3

People

Founders
1
Rosana Kapeller
Rosana Kapeller

Rosana Kapeller

Rosana Kapeller has over 15 years leadership experience in the biotechnology industry. Prior to joining Nimbus, she was Vice President, Research and Co-Founder of Aileron Therapeutics. From 2005 to 2009, Dr. Kapeller led the development of Aileron’s “Stapled Peptide” technology and the first stapled-peptide development candidate. Under her scientific leadership, Aileron secured $60 million in venture financing over its first 4 years. Prior to co-founding Aileron, Dr. Kapeller held positions of increasing responsibility at Millennium Pharmaceuticals most recently serving as Director, Department of Molecular and Cellular Biology. Rosana earned her M.D. from Rio de Janeiro State University in Brazil, and her Ph.D. from Tufts University Medical School, where she trained with Dr. Lewis C. Cantley. She conducted her post-doctoral research work at the Dana-Farber Cancer Institute where she was named a David Abraham Fellow in Pediatric Oncology.

current job

ROME Therapeutics
ROME Therapeutics

organization founded

2

Rosana Kapeller

Employee Profiles
9
Keith Wilcoxen

Keith Wilcoxen

Executive Vice President, Early Development

Nurjana Bachman

Nurjana Bachman

SVP, Corporate Development and Strategy

Enrique Garcia-Rivera

Director, Data Science

Rosana Kapeller

Rosana Kapeller

Co-founder, President and CEO

Donna Romero

Donna Romero

SVP of Chemistry

Kira Christenson Nelson

Kira Christenson Nelson

VP of Finance

Wenyan Miao

Wenyan Miao

VP of Biology and Preclinical Development

Dennis Zaller

Dennis Zaller

Chief Scientific Officer

Activity

Recent News
4
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month